Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Gibco™ CTS™ Detachable Dynabeads™ Release Buffer

Catalog No. A5588303
Change view
Click to view available options
Quantity:
212 mL
400 mL
750 mL
3 product options available for selection
Product selection table with 3 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
A5588303 212 mL
A5588301 400 mL
A5588302 750 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 3 options available.
3 options
Catalog No. A5588303 Supplier Gibco™ Supplier No. A5588303
Only null left
Add to Cart
Add to Cart

The Gibco CTS Detachable Dynabeads Release Buffer is for use with CTS Detachable Dynabeads magnetic beads. When used together, they empower users with a first-of-its-kind cGMP cell selection technology that has an active release mechanism for process development, clinical trial, and commercial manufacturing use.

The Gibco CTS Detachable Dynabeads Release Buffer is for use with CTS Detachable Dynabeads magnetic beads. When used together, they empower users with a first-of-its-kind cGMP cell selection technology that has an active release mechanism for process development, clinical trial, and commercial manufacturing use.

Features of the CTS Detachable Dynabeads Release Buffer (when used with CTS Detachable Dynabeads magnetic beads) include:

  • Empowers users with process flexibility by allowing active release of beads from target cells at any time
  • Optimizes target cell purity, yield, activation profile, and desired phenotype thanks to the active release mechanism that gives users more control
  • Provides an automation-friendly solution by working directly with the CTS DynaCellect Magnetic Separation System
  • Enables consistent performance in light of biological variability within processes
  • Is suitable for both autologous and allogeneic cell therapy manufacturing processes

The CTS Detachable Dynabeads Release Buffer has an active ingredient, biotin, that competitively displaces a biotin derivative on the surface of CTS Detachable Dynabeads magnetic beads. This proprietary mechanism allows users to achieve active release of the beads from target cells at any time within their process. And when used on the CTS DynaCellect Magnetic Separation System, these products deliver automation, flexibility, and scalability in cell therapy manufacturing workflows.

The CTS Detachable Dynabeads Release Buffer also includes Drug Master Files (DMFs) to support cross-referencing in regulatory submissions.

Specifications

Color Clear
Concentration 5 mM
For Use With (Application) Cell Therapy
For Use With (Equipment) CTS DynaCellect Magnetic Separation System
pH 7.0 to 7.4
Physical Form Liquid
Quantity 212 mL
Solution Type Buffer
Grade GMP
Are CTS Dynabeads and CTS Detachable Dynabeads for clinical trial and commercial manufacturing use?

Yes, CTS Dynabeads and CTS Detachable Dynabeads are GMP-grade and CTS-branded, which means that they are eligible for use in process development, clinical trials, and commercial manufacturing.

Thermo Fisher Scientific’s Cell Therapy Systems (CTS) translates to cGMP manufacturing, testing, and traceability documentation (such as Drug Master Files and Regulatory Support Files) for customer filing needs, and a proven track record of use in many clinical trials and commercialized drugs on the market.

The CTS Dynabeads portfolio, specifically, has been actively used in over 200 clinical trials in 2023 as well as in a number of FDA-approved drugs for commercial use.

Can the CTS Detachable Dynabeads Release Buffer be filtered before use?

The CTS Detachable Dynabeads Release Buffer can be filtered with a 0.2 µM PVDF filter before use. Filtration does not negatively affect product performance.

Is there a probability that the recombinant human albumin in the CTS Detachable Dynabeads Release Buffer may develop aggregates?

There is a very low probability that the CTS Detachable Dynabeads Release Buffer may develop minor albumin aggregates after agitation. However, internal studies and multiple publications have shown that albumin aggregates do not affect product quality or performance. Please refer to the Certificate of Analysis that contains a similar statement.

If desired, the product can be filtered with a 0.2 µM PVDF filter before use. Filtration does not affect product performance.

What are the shipping and storage and conditions for the CTS Detachable Dynabeads Release Buffer?

The CTS Detachable Dynabeads Release Buffer is shipped at 2-8 degrees C. We recommend storing it at 2-8 degrees C, protected from light.

What is the shelf-life for the CTS Detachable Dynabeads Release Buffer?

At the time of launch to market for the CTS Detachable Dynabeads Release Buffer in September 2023, the shelf-life was 12 months, but our plan is to extend the shelf-life to 18, 24, 36, 48, and 60 months on a rolling basis. Therefore, our expectation is that the shelf-life will be 5 years by the year 2028.

How does the active release mechanism work for CTS Detachable Dynabeads?

CTS Detachable Dynabeads are meant to be used with the CTS Detachable Dynabeads Release Buffer that comes in a bioprocess container compatible with our CTS DynaCellect Magnetic Separation System for automated workflows.

After the isolation step, the Dynabeads-bound T cells are incubated with the CTS Detachable Dynabeads Release Buffer to actively detach the cells from the Dynabeads. The CTS Detachable Dynabeads Release Buffer contains d-biotin that outcompetes a biotin derivative on the surface of CTS Detachable Dynabeads. It is not an enzymatic reaction.

Users may then rely on the CTS DynaCellect Magnetic Separation System to magnetically separate CTS Detachable Dynabeads from target T cells so they are left with a highly pure target T cell population in the positive fraction.

Do I need to purchase any other product along with CTS Detachable Dynabeads CD3/CD28 (Cat. No. A56996) to perform the active release of the CTS Detachable Dynabeads CD3/CD28?

Yes, you would need to also purchase the CTS Detachable Dynabeads Release Buffer in order to take advantage of the active release mechanism for CTS Detachable Dynabeads CD3/CD28. The CTS Detachable Dynabeads Release Buffer contains d-biotin that outcompetes a biotin derivative on the surface of CTS Detachable Dynabeads CD3/CD28. It is not an enzymatic reaction.

After the active release of CTS Detachable Dynabeads CD3/CD28, you may use the CTS DynaCellect Magnetic Separation System to magnetically separate the CTS Detachable Dynabeads CD3/CD28 from target T cells so that you are left with a highly pure target T cell population in the positive fraction.

Are CTS Detachable Dynabeads compatible with any cell culture media?

Due to the presence of biotin in the CTS Detachable Dynabeads Release Buffer, we do not recommend using CTS Detachable Dynabeads with media that already contain high amounts of biotin, such as RPMI media. Instead, we recommend pairing with media such as our CTS OpTmizer SFM and CTS OpTmizer Pro SFM.

Note: Internal studies have shown that the biotin in the CTS Detachable Dynabeads Release Buffer does not have any impact on cell phenotype or viability.

When using CTS Detachable Dynabeads, what is the level of residual Dynabeads left after the bead removal step?

This depends on the total number of cells that you are processing in a single run and the total number of Dynabeads used. However, our large-scale studies with 10-liter volumes on the CTS DynaCellect Magnetic Separation System yielded less than 25 residual Dynabeads per 3 million cells. And with 1-liter volumes, performance was even better as we observed less than 5 residual Dynabeads per 3 million cells (again in internal studies).

As a reference point, most regulatory agencies have an unofficial minimum threshold of 100 residual beads per 3 million cells.

Can I try out CTS Detachable Dynabeads but do so manually with columns, and not with the CTS DynaCellect Magnetic Separation System?

All of our CTS Detachable Dynabeads products are intended to be used with the CTS DynaCellect Magnetic Separation System. While small DynaMag magnets can be used to assess the functionality of the product in a laboratory scale, it does not allow you to see the full benefits or accurate performance should you decide to scale up to clinical or commercial manufacturing.

Using our CTS Detachable Dynabeads without the CTS DynaCellect Magnetic Separation System is not representative of the yield and purity obtained in the automated closed system.

What is the level of support offered when using CTS Dynabeads and CTS Detachable Dynabeads in clinical trials and commercial manufacturing?

Our CTS Dynabeads and CTS Detachable Dynabeads are supported with Drug Master Files (DMFs), Regulatory Support Files (RSFs), and other traceability documentation.

We have dedicated resources from our Quality and Regulatory teams to support customers who enter into a Commercial Supply Agreement with us.


For Research Use or Manufacturing of Cell, Gene, or Tissue-Based Products. CAUTION: Not intended for direct administration into humans or animals.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.